Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQB3525 in Advanced Bone Sarcomas
NCT04690725Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2020
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
A Phase 2 trial of TQ-B3525 in bone sarcoma, osteosarcoma (OS), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
TQ-B3525
03
Conditions
bone sarcomaosteosarcoma (OS)
Beyond the preview
Go deeper on NCT04690725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04690725.